RecruitingNCT05714124

Liver Embolization Approaches for Tumor Management

Liver Embolization Approaches for Tumor Management - Retrospective and Prospective Analysis of the Short-, Medium-, and Long-term Clinical Course of Patients Subjected to Embolization Treatment for Primary and Secondary Liver Neoplasms


Sponsor

IRCCS San Raffaele

Enrollment

580 participants

Start Date

May 21, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this evaluate short, medium and long term outcome of the different embolization techniques in patients with primary and secondary hepatic tumors. The main aim is to evaluate progression free survival following embolization in this study population or evaluate residual hepatic volume in cases in which these techniques are used to induce liver regeneration. This study is an observational registry - all patients will follow their normal therapeutic and treatment scheme as per clinical practice, without any additional intervention.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting data on different liver embolization techniques — procedures that block blood supply to liver tumors — to compare their outcomes, complications, and best uses across patients with primary or secondary liver cancer. **You may be eligible if...** - You are 18 or older - You have primary liver cancer (such as hepatocellular carcinoma) or cancer that has spread to the liver from elsewhere - Your cancer is not suitable for surgery or ablation, OR you are having liver embolization to prepare for major surgery - You are willing to sign informed consent **You may NOT be eligible if...** - You are pregnant - You have a bleeding disorder that cannot be corrected - You have widespread cancer throughout the body beyond the liver - You have certain abnormal blood vessel connections (biliodigestive shunt) or excessive blood flow to the lungs from the liver Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEmbolization

Endovascular treatment for patients with primary and secondary liver tumors


Locations(1)

IRCCS Ospedale San Raffaele

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05714124


Related Trials